Published on 8 May 2024 on GuruFocus.com via Yahoo Finance
Inspire Medical Systems Inc (INSP) Surpasses Revenue Estimates and Narrows Quarterly Loss
Revenue: Reported $164.0 million for Q1 2024, a 28% increase year-over-year, surpassing the estimate of $161.44 million.Net Loss: Recorded at $10.0 million for Q1 2024, showing improvement from a net loss of $15.4 million in Q1 2023, and was below below the estimated net loss of $19.86 million.Earnings Per Share (EPS): Reported at -$0.34, an improvement from -$0.53 year-over-year, and better better than the estimated -$0.65.Gross Margin: Achieved 84.9% in Q1 2024, slightly up from 84.4% in the same quarter last year.Operating Expenses: Increased to $154.5 million, up 21% compared to Q1 2023, reflecting investments in sales, marketing, and product development.New U.S. Centers and Territories: Activated 66 new U.S. centers and created 11 new U.S. sales territories in Q1 2024.2024 Full Year Guidance: Revenue guidance increased to between $783 million and $793 million, indicating expected growth of 25% to 27% over 2023.
Warning! GuruFocus has detected 3 Warning Signs with INSP.